- Home
- MOLN vs INFU Comparison
MOLN vs INFU Comparison
Compare MOLN & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MOLN | INFU |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.5M | 197.0M |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | MOLN | INFU |
|---|---|---|
| Price | $4.18 | $12.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $8.38 | ★ $15.00 |
| AVG Volume (30 Days) | 1.2K | ★ 85.5K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | N/A | $3.20 |
| Revenue Next Year | $374.07 | $7.31 |
| P/E Ratio | ★ N/A | $61.00 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $3.53 | $7.29 |
| 52 Week High | $5.36 | $12.97 |
Technical Indicators
Market Signals| Indicator | MOLN | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 58.30 |
| Support Level | $4.13 | $11.79 |
| Resistance Level | $4.19 | $12.97 |
| Average True Range (ATR) | 0.07 | 0.30 |
| MACD | -0.03 | -0.10 |
| Stochastic Oscillator | 18.33 | 51.47 |
Price Performance
Historical ComparisonAbout MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.